Shares of Intra-Cellular Therapies Inc. (NASDAQ:ITCI) are trading higher Monday after Johnson & Johnson agreed to acquire the company. What To Know: Johnson & Johnson on Monday entered into a ...
Track the latest Intra-Cellular Therapies insider trading activity. Stay informed on recent buys, sells, and market impact for Intra-Cellular Therapies stock. Insider trading activity involves company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback